Drug Profile
Amlodipine/losartan - HanAll Biopharma
Alternative Names: HL-008; Losartan/amlodipine - HanAll BiopharmaLatest Information Update: 14 Mar 2016
Price :
$50
*
At a glance
- Originator HanAll Biopharma
- Class Antihypertensives; Dihydropyridines; Heart failure therapies; Imidazoles; Ischaemic heart disorder therapies; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; Cytochrome P 450 enzyme system inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 14 Mar 2016 No recent reports on development identified - Phase-I for Hypertension in South Korea (PO)
- 14 Mar 2016 No recent reports on development identified - Preclinical for Hypertension in USA (PO)